Your browser doesn't support javascript.
loading
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis.
Song, Paula; Li, Shufeng; Lewis, Matthew A; Fiorentino, David F; Chung, Lorinda.
Afiliación
  • Song P; Division of Rheumatology, Columbia University School of Medicine, New York, New York.
  • Li S; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
  • Lewis MA; Department of Urology, Stanford University School of Medicine, Palo Alto, California.
  • Fiorentino DF; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
  • Chung L; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
JAMA Dermatol ; 159(3): 308-313, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36753129
Importance: Degos-like lesions are cutaneous manifestations of a small-vessel vasculopathy that appear as atrophic, porcelain-white papules with red, telangiectatic borders. No study has adequately examined Degos-like lesions in patients with systemic sclerosis (SSc). Objective: To characterize the serologic, cutaneous, and internal organ manifestations associated with Degos-like lesions in a large cohort of patients with SSc. Design, Settings, and Participants: This retrospective cohort study involved adult patients with SSc who were seen at Stanford Rheumatologic Dermatology Clinic between January 1, 1998, and December 31, 2018. Participants fulfilled the 2013 classification criteria for SSc. Data analysis was conducted from February 1 to June 1, 2019. Main Outcomes and Measures: Data on demographic characteristics; autoantibody status; clinical characteristics, including cutaneous and systemic manifestations of SSc; and presence of Degos-like lesions were collected. Results: The cohort comprised 506 patients with SSc (447 females [88.3%]; mean [SD] age at first non-Raynaud disease symptoms, 46.1 [15.2] years). Twenty-seven patients (5.3%) had Degos-like lesions, of whom 24 (89.0%) had lesions affecting the fingers. Patients with Degos-like lesions were more likely to have diffuse cutaneous SSc compared with patients without lesions (15 [55.6%] vs 181 [37.8%]; P = .04). Degos-like lesions were also associated with acro-osteolysis (10 [37.0%] vs 62 [12.9%]; P < .01), digital ulcers (15 [55.6%] vs 173 [36.1%]; P = .04), and calcinosis (15 [55.6%] vs 115 [24.0%]; P < .01). While Degos-like lesions were not associated with internal organ manifestations, such as scleroderma renal crisis, interstitial lung disease, or pulmonary arterial hypertension, there was P < .10 for the association with gastric antral vascular ectasia. Conclusions and Relevance: Results of this study suggest an association of Degos-like lesions with diffuse cutaneous SSc and other cutaneous manifestations of vasculopathy, including acro-osteolysis, calcinosis, and digital ulcers. A prospective longitudinal study is warranted to examine the onset of Degos-like lesions and to elucidate whether these lesions play a role in SSc.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Vasculares / Calcinosis / Acroosteólisis Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: JAMA Dermatol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Enfermedades Vasculares / Calcinosis / Acroosteólisis Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Revista: JAMA Dermatol Año: 2023 Tipo del documento: Article